4.00 Credits
Translational science describes the process of moving basic research and technology out of the laboratory into commercial ventures that allow the general public to benefit from the discoveries. This discipline is dependent upon the integration of science and business. Many universities, research institutions and independent parties are investing in accelerators and business incubators to support the commercialization of emergent technologies, encouraging scientists to think like entrepreneurs and appreciate the commercialization potential of their research. This course was created in partnership with the Wistar Institute, a preeminent cancer research institute in Philadelphia, to provide students with hands-on experience in translational science, leveraging real intellectual property (IP). Teams of students will select from an offering of IP/technology that Wistar is pursuing both in the laboratory and as prospective commercial opportunities. To the extent possible, each team will comprise students from different majors (ISBT, BIO, MGT). The students will familiarize themselves with the underlying science/technology by directly interacting with the inventor scientist, identify the unmet needs the science/technology addresses, research and characterize key commercialization issues such as IP, market opportunity, competition, regulatory pathways, and potential customers. At the end of the semester each team will develop a business pitch that addresses the scientific merit, value proposition, overall feasibility and route to commercialization of their selected technology. There will be a formal presentation to a panel of judges, including angel and institutional investors, the objective of which will be to convince the panel of the merits of investing in the technology opportunity.